SRP (Zwaartepunt): Targeting residual cancer cells: myeloma and melanoma as model diseases

Project Details

Description

Anti-tumor vaccination requires the identification of target antigens on resistant tumor subpopulations, adequate immune competence of the patients and the availability of efficient vaccination techniques.
AcronymSRP14
StatusFinished
Effective start/end date1/11/1231/10/17

Flemish discipline codes

  • Immunology
  • Oncology
  • Hematology
  • Physiology
  • Laboratory medicine

Keywords

  • Dendritic Cells
  • Tonic Pain
  • Evoked Potentials
  • Bispecific Antibodies
  • Immunotherapy
  • Immunology
  • Oncology